Katie Gudiksen, Ph.D., is a Senior Health Policy Researcher for The Source on Healthcare Price and Competition. She is a recent graduate of the UCSF/UC Law SF Master of Science in Health Policy and Law program, where she studied policy solutions to promote competition in the pharmaceutical industry. Prior to joining The Source, she co-founded a cancer diagnostics company and worked as Director of Technology where she worked to develop technologies to detect biomarker signatures for aggressive prostate cancer. She also holds an A.M. and Ph.D. in Chemistry from Harvard University and a B.S. and B.A. from Hope College.